Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 11, 2011 - Issue 2
Submit an article Journal homepage
463
Views
19
CrossRef citations to date
0
Altmetric
Theme: Anxiety disorders - Review

Assessment of obsessive–compulsive disorder: review and future directions

Kristen Benito Pediatric Anxiety Research Clinic, Brown University Medical School, 1 Hoppin Street, 2nd Floor, Providence, RI 02903, USA. [email protected]; Pediatric Anxiety Research Clinic, Brown University Medical School, 1 Hoppin Street, 2nd Floor, Providence, RI 02903, USA. [email protected]
&
Eric A Storch Departments of Pediatrics and Psychiatry, University of South Florida, FL, USA; Departments of Pediatrics and Psychiatry, University of South Florida, FL, USA
Pages 287-298 | Published online: 09 Jan 2014

References

  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th Edition – Text Revision). American Psychiatric Association, DC, USA (2000).
  • Samuels J, Nestadt G. Epidemiology and genetics of obsessive–compulsive disorder. Int. Rev. Psychiatry9, 61–72 (1997).
  • Karno M, Golding JM. Obsessive compulsive disorder. In: Pediatric Disorders in America. Tovins LN, Refier DA (Eds). Free Press, NY, USA, 204–219 (1991).
  • National Institute of Mental Health, National Institutes of Health. A Real Illness: Obsessive–Compulsive Disorder. US Department of Health and Human Services, MD, USA (2000).
  • National Institute of Mental Health. Facts About Obsessive Compulsive Disorder. National Institute of Mental Health, MD, USA (1999).
  • Foa EB, Liebowitz MR, Kozak MJ et al. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive–compulsive disorder. Am. J. Psychiatry162, 151–161 (2005).
  • Team PS. Cognitive–behavior therapy, sertraline, and their combination for children and adolescents with obsessive–compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA292, 1969–1976 (2004).
  • Spengler P, Jacobi DM. Assessment and treatment of obsessive–compulsive disorder in college age students and adults. J. Ment. Health Counsel.20(2), 95–111 (1998).
  • Heyman I, Fombonne E, Simmons H, Ford T, Meltzer H, Goodman R. Prevalence of obsessive–compulsive disorder in the British nationwide survey of child mental health. Int. Rev. Psychiatry15, 178–184 (2003).
  • Rasmussen SA, Eisen JL. The epidemiology and differential diagnosis of obsessive compulsive disorder. J. Clin. Psychiatry53, 4–10 (1992).
  • McKay D, Abramowitz JS, Calamari JE et al. A critical evaluation of obsessive disorder subtypes: symptoms versus mechanisms. Clin. Psychol. Rev.24, 283–313 (2004).
  • Merlo LJ, Storch EA, Murphy TK, Goodman WK, Geffken GR. Assessment of pediatric obsessive–compulsive disorder: a critical review of current methodology. Child Psychiatry Hum. Dev.36, 195–214 (2005).
  • Grabill KM, Merlo LJ, Duke D et al. Assessment of obsessive compulsive disorder: a review. J. Anxiety Disord.22, 1–7 (2008).
  • Mayerovich JI, du Fort GG, Kakuma R, Bland RC, Newman SC, Pinard G. Treatment seeking for obsessive–compulsive disorder: role of obsessive–compulsive disorder symptoms and comorbid psychiatric diagnoses. Compr. Psychiatry44, 162–168 (2003).
  • Leonard H, Swedo S, Lenane MC. A 2- to 7-year follow-up study of 54 obsessive–compulsive children and adolescents. Arch. Gen. Psychiatry50, 429–439 (1993).
  • Foa EB, Kozak MJ, Salkovskis P, Coles ME, Amir N. The validation of a new obsessive–compulsive disorder scale: the obsessive–compulsive inventory. Psychol. Assess.10, 206–214 (1998).
  • Obsessive Compulsive Cognitions Working Group. Psychometric validation of the obsessive belief questionnaire and interpretation of intrusions inventory – part 2: factor analyses and testing a brief version. Behav. Res. Ther.43, 1527–1543 (2005).
  • Coles ME, Cook LM, Blake TR. Assessing obsessive compulsive symptoms and cognitions on the internet: evidence for the comparability of paper and internet administration. Behav. Res. Ther.45, 2232–2240 (2007).
  • Goodman WL, Price LH, Rasmussen SA, Mazure C. The Yale–Brown Obsessive Compulsive Scale (Y–BOCS): validity. Arch. Gen. Psychiatry46, 1012–1016 (1989).
  • Rosenfeld R, Dar R, Anderson D, Kobak KA, Greist JH. A computer-administered version of the Yale–Brown Obsessive–Compulsive Scale. Psychol. Assess.4, 329–332 (1992).
  • Baer L, Brown-Beasley MW, Sorce J, Henriques AI. Computer-assisted telephone administration of a structured interview for obsessive–compulsive disorder. Am. J. Psychiatry150, 1737–1738 (1993).
  • Marks I, Baer L, Greist JH et al. Home self-assessment of obsessive–compulsive disorder. Use of a manual and a computer-conducted telephone interview: two UK–US studies. J. Clin. Psychiatry60, 545–549 (1998).
  • Herman S, Koran LM. In vivo measurement of obsessive–compulsive disorder symptoms using palmtop computers. Comput. Human Behav.14(449–462) (1998).
  • Baer L, Minichiello WE. Internet assessment of obsessive–compulsive disorder. J. Clin. Psychiatry67, 1473 (2006).
  • Donker T, van Straten A, Marks I, Cuijpers P. A brief web-based screening questionnaire for common mental disorders: development and validation. J. Med. Internet Res.11, e19 (2009).
  • Farvolden P, McBride C, Bagby RM, Ravitz P. A web-based screening instrument for depression and anxiety disorders in primary care. J. Med. Internet Res.29, e23 (2003).
  • Weissman MM, Broadhead WE, Olfson M et al. A diagnostic aid for detecting (DSM-IV) mental disorders in primary care. Gen. Hosp. Psychiatry20, 1–11 (1998).
  • Steketee G, Frost R, Bogart K. The Yale–Brown Obsessive Compulsive Scale: interview versus self-report. Behav. Res. Ther.34, 675–684 (1996).
  • Goodman WK, Price LH, Rasmussen SA et al. The Yale–Brown Obsessive Compulsive Scale: I. Development, use, and reliability. Arch. Gen. Psychiatry46(1006–1011) (1989).
  • Federici A, Summerfeldt LJ, Harrington JL et al. Consistency between self-report and clinician-administered versions of the Yale–Brown Obsessive–Compulsive scale. J. Anxiety Disord.24(7), 729–733 (2010).
  • Foa EB, Huppert JD, Leiberg S et al. The Obsessive–Compulsive Inventory: development and validation of a short version. Psychol. Assess.14, 485–496 (2002).
  • Hajcak G, Huppert JD, Simmons RF, Foa EB. Psychometric properties of the OCI–R in a college sample. Behav. Res. Ther.42, 115–123 (2004).
  • Gonner S, Ecker W, Leonhart R. Diagnostic discrimination of patients with different OCD main symptom domains from each other and from anxious and depressive controls. J. Psychopathol. Behav. Assess.31, 159–167 (2009).
  • Watson D, Wu KD. Development and validation of the Schedule of Compulsions, Obsessions, and Pathological Impulses (SCOPI). Assessment12, 50–65 (2005).
  • Abramowitz JS, Deacon BJ, Olatunji BO et al. Assessment of obsessive–compulsive symptom dimensions: development and evaluation of the dimensional Obsessive–Compulsive Scale. Psychol. Assess.22, 180–198 (2010).
  • Derogatis LR. SCL–90–R, Administration, Scoring, and Procedures Manual – I for the R(evised) version. Johns Hopkins University School of Medicine, MD, USA (1977).
  • Woody SR, Steketee G, Chambless DL. The usefulness of the Obsessive–Compulsive Scale of the Symptom Checklist-90-Revised. Behav. Res. Ther.33, 607–611 (1995).
  • Storch EA, Bagner D, Merlo LJ et al. Florida Obsessive Compulsive Inventory: development, reliability, and validity. J. Clin. Psychol.63, 851–859 (2007).
  • Aldea MA, Geffken GR, Jacob ML, Goodman WK, Storch EA. Further psychometric analysis of the Florida Obsessive–Compulsive Inventory. J. Anxiety Disord.23, 124–129 (2009).
  • Aldea MA, Rahman O, Storch EA. The psychometric properties of the Florida Obsessive Compulsive Inventory: examination in a non-clinical sample. Indiv. Differ. Res.7, 228–238 (2009).
  • Matthews CA, Jang KL, Hami S, Stein MB. The structure of obsessionality among young adults. Depress. Anxiety20, 77–85 (2004).
  • Kazarian SS, Evans DR, Lefave K. Modification and factorial analysis of the Leyton Obsessional Inventory. J. Clin. Psychol.33, 422–425 (1977).
  • Cashel ML. Child and adolescent psychological assessment: current clinical practices and the impact of managed care. Prof. Psychol. Res. Pr.33, 446–453 (2002).
  • Anderson DA, Paulosky CA. A survey of the use of assessment instruments by eating disorder professionals in clinical practice. Eat Weight Disord.9, 238–241 (2004).
  • Hunsley J. Advancing the role of assessment in evidence-based psychological practice. Clin. Psychol. Sci. Pract.16(2), 202–205 (2009).
  • Rettew DC, Lynch AD, Achenbach TM, Dumenci L, Ivanova MY. Meta-analyses of agreement between diagnoses made from clinical evaluations and standardized diagnostic interviews. Int. J. Meth. Psych. Res.18, 169–184 (2009).
  • Jewell J, Handwerk M, Almquist J, Lucas C. Comparing the validity of clinician-generated diagnosis of conduct disorder to the Diagnostic Interview Schedule for Children. J. Clin. Child Adolesc. Psychol.33, 536–546 (2004).
  • Tenney NH, Schotte CK, Denys DA, Van Megen HJ, Westenberg HG. Assessment of DSM-IV personality disorders in obsessive–compulsive disorder: comparison of clinical diagnosis, self-report questionnaire, and semi-structured interview. J. Pers. Disord.17, 550–561 (2003).
  • Jensen-Doss A, Weisz JR. Diagnostic agreement predicts treatment process and outcomes in youth mental health clinics. J. Consult. Clin. Psychol.76, 711–722 (2008).
  • Garcia AM, Freeman JB, Himle MB et al. Phenomenology of early childhood onset obsessive–compulsive disorder. J. Psychopathol. Behav. Assess.31, 104–111 (2009).
  • Nicolini H, Arnold P, Nestadt G, Lanzagorta N, Kennedy JL. Overview of genetics and obsessive compulsive disorder. Psychiatry Res.170, 7–14 (2009).
  • Hasler G, Pinto A, Greenberg B et al. Familiality of factory analysis-derived YBOCS dimensions in OCD-affected sibling pairs from the OCD collaborative genetic study. Biol. Psychiatry61, 617–625 (2007).
  • Shaffer D, Fisher PW, Lucas CP. Respondent-based interviews. In: Diagnostic Assessment in Child and Adolescent Psychopathology. Shaffer D, Richters JE (Eds). The Guilford Press, NY, USA, 3–33 (1999).
  • Brown TA, Di Nardo PA, Lehman CL, Campbell LA. Reliability of DSM-IV anxiety and mood disorders: implications for the classification of emotional disorders. J. Abnorm. Psychol.111, 49–58 (2001).
  • Summerfeldt LJ, Antony MM. Structured and semistructured diagnostic interviews. In: Handbook of Assessment and Treatment Planning for Psychological Disorders. Antony MM, Barlow DH (Eds). The Guilford Press, NY, USA, 3–37 (2002).
  • Silverman WK, Albano AM. The Anxiety Disorders Interview Schedule for DSM-IV: Child and Parent Versions. Psychological Corporation, TX, USA (1996).
  • Brown TA, Chorpita BF, Barlow DH. Structural relationships among dimensions of the DSM-IV anxiety and mood disorders and dimensions of negative affect, positive affect, and autonomic arousal. J. Abnorm. Psychol.107, 179–192 (1998).
  • Wood JJ, Piacentini J, Bergman RL, McCracken J, Barrios V. Concurrent validity of the anxiety disorders interview schedule for DSM-IV: child and parent versions. J. Am. Acad. Child Adolesc. Psychiatry40, 937–944 (2002).
  • First MB, Gibbon M. The Structured Clinical Interview for DSM-IV Axis I Disorders (SCID I) and the Structured Clinical Interview for DSM-IV Axis II Disorders (SCID II). In: Comprehensive Handbook of Psychological Assessment: Volume 2. Personality Assessment.Hisenroth MJ, Segal DL (Eds). Wiley, NJ, USA, 134–143 (2004).
  • Basco MR, Bostic JQ, Davies D, Rush AJ, Witte B, Hendrickse WA. Methods to improve diagnostic accuracy in a community mental health setting. Am. J. Psychiatry157, 1599–1605 (2000).
  • Kranzler HR, Kadden RM, Babor TF, Tennen H, Rounsaville BJ. Validity of the SCID in substance abuse patients. Addiction91, 859–868 (1996).
  • Kranzler HR, Kadden R, Burleson J, Babor TF, Apter A, Rounsaville BJ. Validity of psychiatric diagnoses in patients with substance use disorders – is the interview more important than the interview? Compr. Psychiatry36, 278–288 (1995).
  • Taylor S, Thordarson DS, Sochting I. Obsessive–compulsive disorder. In: Handbook of Assessment and Treatment Planning for Psychological Disorders. Antony MM, Barlow DH (Eds). The Guilford Press, NY, USA, 182–214 (2002).
  • Storch EA, Rasmussen SA, Price LH, Larson MJ, Murphy TK, Goodman WK. Development and validation of the Yale–Brown Obsessive–Compulsive Scale – Second Edition. Psychol. Assess.22, 223–232 (2010).
  • Frost RO, Steketee G, Krause MS, Trepanier KL. The relationship of the Yale–Brown Obsessive Compulsive Scale (Y–BOCS) to other measures of obsessive compulsive symptoms in a nonclinical population. J. Pers. Assess.65, 158–168 (1995).
  • Taylor S. Assessment of obsessions and compulsions: reliability, validity, and sensitivity to treatment effects. Clin. Psychol. Rev.15, 261–296 (1995).
  • Kim SW, Dysken MW, Kuskowski M. The Symptoms Checklist-90: Obsessive–Compulsive subscale: a reliability and validity study. Psychiatry Res.41, 37–44 (1992).
  • Kim SW, Dysken MW, Kuskowski M, Hoover KM. The Yale–Brown Obsessive Compulsive Scale (Y–BOCS) and the NIMH Global Obsessive Compulsive Scale (NIMH-GOCS): a reliability and validity study. Int. J. Meth. Psychiatr. Res.3, 37–44 (1993).
  • Tek C, Ulug B, Gursoy RB et al. Yale–Brown Obsessive Compulsive Scale and the US National Institute of Mental Health Global Obsessive Compulsive Scale in Turkish: reliability and validity. Acta Psychiatr. Scand.91, 410–413 (1995).
  • Barrett P, Farrell L, Dadds M, Boulter N. Cognitive–behavioral family treatment of childhood obsessive–compulsive disorder: long-term follow-up and predictors of outcome. J. Am. Acad. Child Adolesc. Psychiatry44, 1005–1014 (2005).
  • Piacentini J, Bergman RL, Jacobs C, McCracken J, Kretchman J. Cognitive–behavior therapy for childhood obsessive–compulsive disorder: efficacy and predictors of treatment response. J. Anxiety Disord.16, 207–219 (2002).
  • Chambless DL, Steketee G. Expressed emotion and behavior therapy outcome: a prospective study with obsessive–compulsive and agoraphobic outpatients. J. Consult. Clin. Psychol.67, 658–665 (1999).
  • Storch EA, Larson MJ, Muroff J et al. Predictors of functional impairment in pediatric obsessive compulsive disorder. J. Anxiety Disord.34, 275–283 (2010).
  • Merlo LJ, Lehmkuhl HD, Geffken GR, Storch EA. Decreased family accommodation associated with improved therapy outcome in pediatric obsessive–compulsive disorder. J. Consult. Clin. Psychol.77, 355–360 (2009).
  • Abramowitz JS, Foa EB. Does major depressive disorder influence outcome of exposure and response prevention for OCD? Behav. Ther.31, 795–800 (2000).
  • de Haan E, Hoodguin KA, Buitelaar JK, Keijsers G. Behavior therapy versus clomipramine in obsessive–compulsive disorders in children and adolescents. J. Am. Acad. Child Adolesc. Psychiatry37, 1022–1029 (1998).
  • Foa EB, Abramowitz JS, Franklin ME, Kozak MJ. Feared consequences, fixity of belief, and treatment outcome in OCD. Behav. Ther.30, 717–724 (1999).
  • Kendall PC, Robin JA, Hedtke KA, Suveg C, Flannery-Schroeder E, Gosch E. Considering CBT with anxious youth? Think exposures. Cogn. Behav. Pract.12, 136–150 (2005).
  • Katerelos M, Hawley LL, Antony MM, McCabe RE. The exposure hierarchy as a measure of progress and efficacy in the treatment of social anxiety disorder. Behav. Modif.32, 504–518 (2008).
  • Calvocoressi L, Mazure CM, Kasl SV et al. Family accommodation of obsessive compulsive symptoms: instrument development and assessment of family behavior. J. Nerv. Ment. Dis.187, 636–642 (1999).
  • Calvocoressi L, Lewis B, Harris M, Trufan SJ. Family accommodation in obsessive compulsive disorder. Am. J. Psychiatry152, 441–443 (1995).
  • Mataix-Cols D, Lawrence N, Wooderson S, Speckens A, Phillips ML. The Maudsley Obsessive–Compulsive Stimuli Set: validation of a standardized paradigm for symptom specific provocation in obsessive–compulsive disorder. Psychiatry Res.168, 238–241 (2009).
  • Steketee G, Chambless DL, Tran GQ, Worden H. Behavioral Avoidance Test for obsessive compulsive disorder. Behav. Res. Ther.43, 73–83 (1996).
  • Mataix-Cols D, Rosario-Campos MC, Leckman JF. A multidimensional model of obsessive–compulsive disorder. Am. J. Psychiatry162, 228–238 (2005).
  • Bloch MH, Landeros-Weisenberger A, Rosario MC, Pittinger C, Leckman JF. Meta-analysis of the symptom structure of obsessive–compulsive disorder. Am. J. Psychiatry165, 1532–1542 (2008).
  • Stewart SE, Rosario MC, Baer L et al. Four-factor structure of obsessive compusive disorder symptoms in children, adolescents, and adults. J. Am. Acad. Child Adolesc. Psychiatry47, 763–772 (2008).
  • Stewart SE, Rosario MC, Brown TA et al. Principal components analysis of obsessive–compulsive disorder symptoms in children and adolescents. Biol. Psychiatry61, 285–291 (2007).
  • Mataix-Cols D, Nakatani E, Micali N, Heyman I. Structure of obsessive–compulsive symptoms in pediatric OCD. J. Am. Acad. Child Adolesc. Psychiatry47, 773–778 (2008).
  • Landeros-Weisenberger A, Bloch MH, Kelmendi B et al. Dimensional predictors of response to SRI pharmacotherapy in obsessive–compulsive disorder. J. Affect. Disord.121, 175–179 (2010).
  • Lawrence N, Wooderson S, Mataix-Cols D, David R, Speckens A, Phillips ML. Decision making and set shifting impairments are associated with distinct symptom dimensions in obsessive–compulsive disorder. Neuropsychology20(409–419) (2006).
  • Mataix-Cols D, Wooderson S, Lawrence N, Brammer MJ, Speckens A, Phillips ML. Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive compulsive disorder. Arch. Gen. Psychiatry61, 564–576 (2004).
  • Rauch SL, Dougherty DD, Shin LM. Neural correlates of factor-analyzed OCD symptom dimensions: a PET study. CNS Spectr.3(37–43) (1998).
  • Menzies RG, de Silva P. Obsessive–Compulsive Disorder: Theory, Research, and Treatment. Wiley, Chichester, UK (2003).
  • Antony MM, Purdon C, Summerfeldt LJ. Psychological Treatment of Obsessive–Compulsive Disorder: Fundamentals and Beyond.American Psychological Association, DC, USA (2007).
  • Rosario-Campos MC, Miguel EC, Quatrano S, Chacon P, Ferrao Y, Findley D. The dimensional Yale–Brown Obsessive–Compulsive Scale (DY–BOCS): an instrument for assessing obsessive–compulsive symptom dimensions. Mol. Psychiatry11, 495–504 (2006).
  • Abrahams E, Silver M. The case for personalized medicine. J. Diabetes Sci. Technol.3, 680–684 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.